Imagen de Portada

The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE ε4 non‐carriers with mild cognitive impairment due to Alzheimer's disease

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Arnold Bakker, Nisha Rani, Richard Mohs, Michela Gallagher
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The HOPE4MCI study: AGB101 treatment reduces entorhinal cortex atrophy in patients with amnestic mild cognitive impairment due to Alzheimer's Disease who are ApoE‐4 non‐carriers
por: Nisha Rani, et al.
Publicado: (2024)

The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD
por: Richard Mohs, et al.
Publicado: (2024)

The HOPE4MCI study: AGB101 treatment normalizes aberrant network activity and slows entorhinal cortex atrophy in patients with amnestic mild cognitive impairment due to Alzheimer's Disease who are ApoE‐4 non‐carriers
por: Arnold Bakker, et al.
Publicado: (2025)

Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment
por: Takuya Ataka, et al.
Publicado: (2024)

Mapping sex differences in brain and cognition in relation to APOE ε4 and amyloid burden: A longitudinal normative modelling study
por: Sivaniya Subramaniapillai, et al.
Publicado: (2026)

Correction to “Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study”
Publicado: (2026)

Electroencephalography‐based signatures of cognitive resilience in individuals with stable mild cognitive impairment despite carrying a high‐risk for progression to dementia
por: Chiara Pappalettera, et al.
Publicado: (2025)

APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics
por: Susan Abushakra, et al.
Publicado: (2024)

Rural‐Urban mild cognitive impairment comparison in West Michigan through EHR
por: Xiaodan Zhang, et al.
Publicado: (2024)

Impact of study partner replacement in a mild cognitive impairment clinical trial
por: Lucy A. Dolmadjian, et al.
Publicado: (2025)

Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
por: Chao‐Yi Wu, et al.
Publicado: (2025)

APOE ε4‐independent pathways predominate in the association between retinal nerve fiber layer thinning and 12‐year incident dementia
por: Yuzhuo Wang, et al.
Publicado: (2025)

Effects of care partner type on outcomes from a multicomponent behavioral intervention for mild cognitive impairment
por: Zhigang Xie, et al.
Publicado: (2026)

Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative
por: Pranitha Y. Premnath, et al.
Publicado: (2024)

Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?
por: Krista Lanctot, et al.
Publicado: (2025)

Vascular cognitive impairment and dementia drug‐development pipeline 2025
por: Ying Xu, et al.
Publicado: (2026)

Effects of multidomain intervention on cognitive function in older adults with cognitive impairment: A multicenter, four‐arm, cluster randomized trial
por: Zhaoxue Yin, et al.
Publicado: (2026)

Activity variability: A novel physical activity metric and its association with cognitive impairment
por: Patrick T. Donahue, et al.
Publicado: (2025)

Response to: Refining the clinical interpretation of activity variability in cognitive impairment: The need for phenotypic specificity
por: Patrick T. Donahue, et al.
Publicado: (2025)

The functional role of the pulvinar in discriminating between objective and subjective cognitive impairment in major depressive disorder
por: Burak Yulug, et al.
Publicado: (2024)

Assessment and treatment of multiply maintained self injury for a visually impaired elementary student with autism
por: Sara K. Snyder, et al.
Publicado: (2024)

Development and classification accuracy of an automated cognitive screening tool combining working memory and connected speech tasks for early detection of cognitive impairment in primary care
por: Robin C. Hilsabeck, et al.
Publicado: (2025)

Incorporating social validity into practice: Treatment progression across pediatric feeding skill domains
por: Tessa Taylor, et al.
Publicado: (2024)

First‐in‐human positron emission tomography study of intranasal insulin in aging and MCI
por: Kiran K. Solingapuram Sai, et al.
Publicado: (2025)

Does ejection fraction matter in choosing between percutaneous coronary intervention and coronary artery bypass surgery?
por: Arnold H. Seto, et al.
Publicado: (2024)

Clinical efficacy of anti‐amyloid antibodies in apolipoprotein E ε4 homozygotes: A Bayesian reanalysis of lecanemab and donanemab phase 3 results
por: Stefan Teipel, et al.
Publicado: (2025)

Individuals with genetic high‐risk for psychosis experience impaired coping styles compared with healthy controls
por: Xiao‐Yang He, et al.
Publicado: (2024)

Association between plasma p‐tau181 levels and the evolution of cognitive and physical performance in a cohort of cognitively impaired older adults with frailty criteria: Longitudinal data from the CogFrail study
por: Davide Angioni, et al.
Publicado: (2026)

Treating cardiac tamponade due to malignant effusion with percutaneous balloon pericardiotomy: Back to the future
por: Adib Chaus, et al.
Publicado: (2024)

Coronary Steal Syndrome due to a Side Branch of the LIMA in Patients Undergoing Coronary Artery Bypass Grafting
por: Adrien Jossart, et al.
Publicado: (2025)

Incidence, progression, and predictors of left atrial appendage sealing after Watchman FLX device implantation with computed tomographic assessment
por: Sung‐Han Yoon, et al.
Publicado: (2024)

Validating cognitive screening in young people with first‐episode psychosis: The CogScreen protocol
por: Alexandra Stainton, et al.
Publicado: (2024)

APOE ‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
por: Mai Othman, et al.
Publicado: (2026)

Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual‐level data from the A4 study of solanezumab
por: Sarah F. Ackley, et al.
Publicado: (2026)

First in‐human experience of miniaturized 4D‐TOE probe supporting M‐TEER
por: Andrea Ruberti, et al.
Publicado: (2024)

Psychometric properties of the Spanish version of the measure of insight into cognition‐self‐report in psychosis‐risk and non‐clinical Mexican young adults
por: Ana Fresán, et al.
Publicado: (2024)

The impact of estimated cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline
por: Adam J Paulsen, et al.
Publicado: (2025)

Successful revascularization of coronary occlusion due to lotus root‐like plaques by IVUS‐based real‐time three‐dimensional wiring using the tip detection method in a patient with cardiac arrest
por: Akihiro Okamoto, et al.
Publicado: (2024)

Comparison of Self‐Expandable Acurate Neo‐2 and Balloon‐Expandable Myval Transcatheter Heart Valves at 4‐Year Follow‐Up
por: Akash Jain, et al.
Publicado: (2025)

Effectiveness and Safety of 4‐Fr Distal Radial Access With Low‐Dose Unfractionated Heparin Versus Proximal Radial Access for Coronary Angiography
por: Hugo Pilichowski, et al.
Publicado: (2025)